Free Trial
NASDAQ:CRDL

Cardiol Therapeutics (CRDL) Stock Price, News & Analysis

Cardiol Therapeutics logo
$1.12 -0.03 (-2.61%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 +0.02 (+2.23%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cardiol Therapeutics Stock (NASDAQ:CRDL)

Key Stats

Today's Range
$1.12
$1.16
50-Day Range
$0.99
$1.53
52-Week Range
$0.77
$2.63
Volume
626,310 shs
Average Volume
384,395 shs
Market Capitalization
$93.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00
Consensus Rating
Buy

Company Overview

Cardiol Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

CRDL MarketRank™: 

Cardiol Therapeutics scored higher than 46% of companies evaluated by MarketBeat, and ranked 619th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardiol Therapeutics has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Cardiol Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about Cardiol Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for Cardiol Therapeutics are expected to grow in the coming year, from ($0.33) to ($0.30) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardiol Therapeutics is -3.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardiol Therapeutics is -3.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cardiol Therapeutics has a P/B Ratio of 11.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cardiol Therapeutics' valuation and earnings.
  • Percentage of Shares Shorted

    2.24% of the float of Cardiol Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardiol Therapeutics has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Cardiol Therapeutics has recently increased by 2.33%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Cardiol Therapeutics does not currently pay a dividend.

  • Dividend Growth

    Cardiol Therapeutics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.24% of the float of Cardiol Therapeutics has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardiol Therapeutics has a short interest ratio ("days to cover") of 4.3.
  • Change versus previous month

    Short interest in Cardiol Therapeutics has recently increased by 2.33%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Cardiol Therapeutics has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Cardiol Therapeutics this week, compared to 1 article on an average week.
  • Search Interest

    17 people have searched for CRDL on MarketBeat in the last 30 days. This is an increase of 113% compared to the previous 30 days.
  • MarketBeat Follows

    15 people have added Cardiol Therapeutics to their MarketBeat watchlist in the last 30 days. This is an increase of 1,400% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardiol Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 5.25% of the stock of Cardiol Therapeutics is held by insiders.

  • Percentage Held by Institutions

    Only 12.49% of the stock of Cardiol Therapeutics is held by institutions.

  • Read more about Cardiol Therapeutics' insider trading history.
Receive CRDL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardiol Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRDL Stock News Headlines

What is HC Wainwright's Estimate for CRDL FY2028 Earnings?
This stock could leave NVDA in the dust
Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel
Cardiol Therapeutics Analyst Ratings
Cardiol Therapeutics Analyst Ratings
See More Headlines

CRDL Stock Analysis - Frequently Asked Questions

Cardiol Therapeutics' stock was trading at $1.28 at the start of the year. Since then, CRDL shares have decreased by 12.5% and is now trading at $1.12.

Cardiol Therapeutics Inc. (NASDAQ:CRDL) announced its quarterly earnings data on Thursday, August, 14th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.11) by $0.04.

Top institutional investors of Cardiol Therapeutics include Tejara Capital Ltd (3.95%), AdvisorShares Investments LLC (1.04%), MMCAP International Inc. SPC (0.35%) and Envestnet Asset Management Inc. (0.22%).

Shares of CRDL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardiol Therapeutics investors own include BMO Capital Markets (), Stifel Nicolaus (), Wunderlich (), Standpoint Research (), Duncan Williams (), Soleil Securities () and Sterne Agee CRT ().

Company Calendar

Last Earnings
8/14/2025
Today
8/27/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRDL
CIK
1702123
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

High Price Target
$9.00
Low Price Target
$7.00
Potential Upside/Downside
+604.2%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.77 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-232.26%
Return on Assets
-158.19%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
2.46
Quick Ratio
2.46

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
11.36

Miscellaneous

Outstanding Shares
83,710,000
Free Float
79,317,000
Market Cap
$95.09 million
Optionable
Not Optionable
Beta
1.05

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:CRDL) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners